Generation bio to participate in 42nd annual cowen health care conference

Cambridge, mass., march 02, 2022 (globe newswire) -- generation bio co. (nasdaq: gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that geoff mcdonough, m.d., president and chief executive officer, will participate in the gene therapy panel discussion at the 42nd annual cowen health care conference on wednesday, march 9 at 12:50 p.m. et.
GBIO Ratings Summary
GBIO Quant Ranking